Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375033 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
Determining the sequence specifity of DNA binding molecules is a non-trivial task. Here we describe the development of a platform for assaying the sequence specificity of DNA ligands using label free detection on high density DNA microarrays. This is achieved by combining Cognate Site Identification (CSI) with Fluorescence Intercalation Displacement (FID) to create CSI–FID. We use the well-studied small molecule DNA ligand netropsin to develop this high throughput platform. Analysis of the DNA binding properties of protein- and small molecule-based libraries with CSI–FID will advance the development of genome-anchored molecules for therapeutic purposes.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Karl E. Hauschild, James S. Stover, Dale L. Boger, Aseem Z. Ansari,